Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）
SHANGHAI, Jan. 9, 2024 /PRNewswire/ -- On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor pimicotinib（ABSK021）...
Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary...
ROCKVILLE, Md. and SUZHOU, China, Jan. 9, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
Chemical.AI partners with NTU Singapore to advance automated and AI-powered research platform for nanomaterials
SINGAPORE, Jan. 9, 2024 /PRNewswire/ -- Chemical.AI recently announced a partnership with Nanyang Technological University, Singapore (NTU Singapore) to advance the automation progress in nanomaterials...
Kia launches Platform Beyond Vehicle business at CES 2024 to go 'Beyond Mobility'
Kia's Platform Beyond Vehicle (PBV) goes 'Beyond Mobility', with adaptability that stands 'Ready to Answer Every Question' Customized vehicles...
GIGABYTE Debuts Next-Gen 16-inch AI Gaming Laptops at CES 2024
TAIPEI, Jan. 9, 2024 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, proudly presents the full lineup of next-gen AI Gaming Laptops at CES...
HISENSE PUSHES THE BOUNDARIES OF DISPLAY TECHNOLOGY AND COMMITMENT TO SCENARIO-BASED LIVING AT CES 2024
President of Hisense Americas, David Gold delivered keynote on Hisense's commitment to bring the world closer by integrating display technologies into everyday life. LAS VEGAS,...
